Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xia Yu Xue Tang
- Development stage
- Unknown
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xia Yu Xue Tang (also known as Xia Yu Blood Tang or Expelling Blood Stasis Decoction) is a classic Traditional Chinese Medicine (TCM) formula first recorded in the *Jingui Yaolue* (Essential Prescriptions from the Golden Cabinet) by Zhang Zhongjing. The formula is composed of three primary medicinal ingredients: *Rheum palmatum* (Da Huang), *Prunus persica* (Tao Ren), and *Eupolyphaga sinensis* (Di Bie Chong). Traditionally, it is indicated for the treatment of internal blood stasis, particularly postpartum abdominal pain and amenorrhea. In modern clinical research, Xia Yu Xue Tang is frequently investigated for its potential anti-fibrotic effects in chronic liver diseases, such as liver cirrhosis and hepatitis. Its mechanism of action is thought to involve the inhibition of the TGF-beta1/Smad signaling pathway, which leads to the suppression of hepatic stellate cell activation and a reduction in the accumulation of extracellular matrix components.
- Other names
- Xia Yu Blood TangExpelling Blood Stasis DecoctionLowering Blood Stasis DecoctionXiayuxue TangXia-Yu-Xue-Tang
Beyond the preview
Go deeper on Xia Yu Xue Tang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xia Yu Xue Tang.